nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—Urinary incontinence—Temozolomide—melanoma	0.00458	0.00755	CcSEcCtD
Eprosartan—Abnormal vision—Carmustine—melanoma	0.00428	0.00705	CcSEcCtD
Eprosartan—Neuritis—Docetaxel—melanoma	0.00422	0.00696	CcSEcCtD
Eprosartan—Arthritis—Bleomycin—melanoma	0.0042	0.00692	CcSEcCtD
Eprosartan—Chills—Vemurafenib—melanoma	0.00418	0.00689	CcSEcCtD
Eprosartan—Abnormal vision—Temozolomide—melanoma	0.00413	0.00682	CcSEcCtD
Eprosartan—Diabetes mellitus—Carmustine—melanoma	0.00409	0.00675	CcSEcCtD
Eprosartan—Otitis media—Docetaxel—melanoma	0.00405	0.00668	CcSEcCtD
Eprosartan—Swelling—Carmustine—melanoma	0.00404	0.00665	CcSEcCtD
Eprosartan—Back pain—Vemurafenib—melanoma	0.00392	0.00647	CcSEcCtD
Eprosartan—Gastroenteritis—Temozolomide—melanoma	0.00388	0.0064	CcSEcCtD
Eprosartan—Rigors—Docetaxel—melanoma	0.00386	0.00637	CcSEcCtD
Eprosartan—Vascular purpura—Temozolomide—melanoma	0.00385	0.00634	CcSEcCtD
Eprosartan—Hot flush—Temozolomide—melanoma	0.00368	0.00606	CcSEcCtD
Eprosartan—Menopausal symptoms—Temozolomide—melanoma	0.00365	0.00601	CcSEcCtD
Eprosartan—Hyponatraemia—Carmustine—melanoma	0.00358	0.00589	CcSEcCtD
Eprosartan—Purpura—Temozolomide—melanoma	0.00357	0.00589	CcSEcCtD
Eprosartan—Cough—Vemurafenib—melanoma	0.00354	0.00583	CcSEcCtD
Eprosartan—Myalgia—Vemurafenib—melanoma	0.00345	0.00569	CcSEcCtD
Eprosartan—Arthralgia—Vemurafenib—melanoma	0.00345	0.00569	CcSEcCtD
Eprosartan—Face oedema—Carmustine—melanoma	0.00344	0.00567	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00343	0.00565	CcSEcCtD
Eprosartan—Ataxia—Carmustine—melanoma	0.00335	0.00552	CcSEcCtD
Eprosartan—Face oedema—Temozolomide—melanoma	0.00332	0.00548	CcSEcCtD
Eprosartan—Bone pain—Docetaxel—melanoma	0.00329	0.00543	CcSEcCtD
Eprosartan—Hypokalaemia—Carmustine—melanoma	0.00324	0.00534	CcSEcCtD
Eprosartan—Ataxia—Temozolomide—melanoma	0.00324	0.00533	CcSEcCtD
Eprosartan—Muscular weakness—Carmustine—melanoma	0.00314	0.00518	CcSEcCtD
Eprosartan—Hypokalaemia—Temozolomide—melanoma	0.00313	0.00516	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Temozolomide—melanoma	0.0031	0.00511	CcSEcCtD
Eprosartan—Hypotension—Vemurafenib—melanoma	0.00309	0.0051	CcSEcCtD
Eprosartan—Influenza like illness—Docetaxel—melanoma	0.00306	0.00505	CcSEcCtD
Eprosartan—Muscular weakness—Temozolomide—melanoma	0.00304	0.005	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Temozolomide—melanoma	0.00304	0.005	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00302	0.00497	CcSEcCtD
Eprosartan—Haematuria—Bleomycin—melanoma	0.003	0.00494	CcSEcCtD
Eprosartan—Sweating increased—Temozolomide—melanoma	0.0029	0.00478	CcSEcCtD
Eprosartan—Oesophagitis—Docetaxel—melanoma	0.00288	0.00475	CcSEcCtD
Eprosartan—Decreased appetite—Vemurafenib—melanoma	0.00288	0.00474	CcSEcCtD
Eprosartan—Bronchitis—Temozolomide—melanoma	0.00286	0.00472	CcSEcCtD
Eprosartan—Fatigue—Vemurafenib—melanoma	0.00285	0.0047	CcSEcCtD
Eprosartan—Constipation—Vemurafenib—melanoma	0.00283	0.00467	CcSEcCtD
Eprosartan—Hyperglycaemia—Carmustine—melanoma	0.00278	0.00458	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Temozolomide—melanoma	0.00276	0.00456	CcSEcCtD
Eprosartan—Pollakiuria—Temozolomide—melanoma	0.00275	0.00453	CcSEcCtD
Eprosartan—Depression—Carmustine—melanoma	0.00274	0.00451	CcSEcCtD
Eprosartan—Renal failure—Carmustine—melanoma	0.0027	0.00445	CcSEcCtD
Eprosartan—Neuropathy peripheral—Carmustine—melanoma	0.00269	0.00443	CcSEcCtD
Eprosartan—Hyperglycaemia—Temozolomide—melanoma	0.00268	0.00442	CcSEcCtD
Eprosartan—Urinary tract infection—Carmustine—melanoma	0.00267	0.0044	CcSEcCtD
Eprosartan—Depression—Temozolomide—melanoma	0.00264	0.00436	CcSEcCtD
Eprosartan—Body temperature increased—Vemurafenib—melanoma	0.00262	0.00431	CcSEcCtD
Eprosartan—Pharyngitis—Dactinomycin—melanoma	0.00261	0.00431	CcSEcCtD
Eprosartan—Neuropathy peripheral—Temozolomide—melanoma	0.0026	0.00429	CcSEcCtD
Eprosartan—Swelling—Docetaxel—melanoma	0.00259	0.00428	CcSEcCtD
Eprosartan—Urinary tract infection—Temozolomide—melanoma	0.00258	0.00425	CcSEcCtD
Eprosartan—Chills—Bleomycin—melanoma	0.00253	0.00417	CcSEcCtD
Eprosartan—Sinusitis—Temozolomide—melanoma	0.00249	0.0041	CcSEcCtD
Eprosartan—Hot flush—Docetaxel—melanoma	0.00245	0.00403	CcSEcCtD
Eprosartan—Hypersensitivity—Vemurafenib—melanoma	0.00244	0.00402	CcSEcCtD
Eprosartan—Oedema peripheral—Carmustine—melanoma	0.00243	0.004	CcSEcCtD
Eprosartan—Menopausal symptoms—Docetaxel—melanoma	0.00243	0.004	CcSEcCtD
Eprosartan—Atrial fibrillation—Docetaxel—melanoma	0.00242	0.00398	CcSEcCtD
Eprosartan—Asthenia—Vemurafenib—melanoma	0.00237	0.00391	CcSEcCtD
Eprosartan—Visual impairment—Carmustine—melanoma	0.00237	0.00391	CcSEcCtD
Eprosartan—Pharyngitis—Temozolomide—melanoma	0.00236	0.0039	CcSEcCtD
Eprosartan—Chills—Dactinomycin—melanoma	0.00236	0.00389	CcSEcCtD
Eprosartan—Oedema peripheral—Temozolomide—melanoma	0.00235	0.00387	CcSEcCtD
Eprosartan—Cardiac failure—Docetaxel—melanoma	0.00235	0.00387	CcSEcCtD
Eprosartan—Pruritus—Vemurafenib—melanoma	0.00234	0.00386	CcSEcCtD
Eprosartan—Hyponatraemia—Docetaxel—melanoma	0.0023	0.00379	CcSEcCtD
Eprosartan—Visual impairment—Temozolomide—melanoma	0.00229	0.00378	CcSEcCtD
Eprosartan—Ill-defined disorder—Bleomycin—melanoma	0.00228	0.00376	CcSEcCtD
Eprosartan—Diarrhoea—Vemurafenib—melanoma	0.00226	0.00373	CcSEcCtD
Eprosartan—Migraine—Docetaxel—melanoma	0.00225	0.00371	CcSEcCtD
Eprosartan—Tinnitus—Temozolomide—melanoma	0.00222	0.00366	CcSEcCtD
Eprosartan—Malaise—Bleomycin—melanoma	0.00222	0.00365	CcSEcCtD
Eprosartan—Dizziness—Vemurafenib—melanoma	0.00219	0.00361	CcSEcCtD
Eprosartan—Ataxia—Docetaxel—melanoma	0.00215	0.00355	CcSEcCtD
Eprosartan—Cough—Bleomycin—melanoma	0.00214	0.00353	CcSEcCtD
Eprosartan—Chills—Temozolomide—melanoma	0.00214	0.00352	CcSEcCtD
Eprosartan—Ill-defined disorder—Dactinomycin—melanoma	0.00213	0.00351	CcSEcCtD
Eprosartan—Vomiting—Vemurafenib—melanoma	0.0021	0.00347	CcSEcCtD
Eprosartan—Chest pain—Bleomycin—melanoma	0.00209	0.00345	CcSEcCtD
Eprosartan—Myalgia—Bleomycin—melanoma	0.00209	0.00345	CcSEcCtD
Eprosartan—Orthostatic hypotension—Docetaxel—melanoma	0.00209	0.00345	CcSEcCtD
Eprosartan—Rash—Vemurafenib—melanoma	0.00209	0.00344	CcSEcCtD
Eprosartan—Dermatitis—Vemurafenib—melanoma	0.00208	0.00344	CcSEcCtD
Eprosartan—Back pain—Carmustine—melanoma	0.00207	0.00342	CcSEcCtD
Eprosartan—Headache—Vemurafenib—melanoma	0.00207	0.00342	CcSEcCtD
Eprosartan—Discomfort—Bleomycin—melanoma	0.00207	0.00341	CcSEcCtD
Eprosartan—Malaise—Dactinomycin—melanoma	0.00207	0.00341	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00206	0.0034	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Docetaxel—melanoma	0.00202	0.00333	CcSEcCtD
Eprosartan—Tremor—Carmustine—melanoma	0.00201	0.00331	CcSEcCtD
Eprosartan—Back pain—Temozolomide—melanoma	0.002	0.0033	CcSEcCtD
Eprosartan—Nausea—Vemurafenib—melanoma	0.00197	0.00324	CcSEcCtD
Eprosartan—Thrombocytopenia—Bleomycin—melanoma	0.00196	0.00324	CcSEcCtD
Eprosartan—Myalgia—Dactinomycin—melanoma	0.00195	0.00322	CcSEcCtD
Eprosartan—Tremor—Temozolomide—melanoma	0.00194	0.0032	CcSEcCtD
Eprosartan—Discomfort—Dactinomycin—melanoma	0.00193	0.00318	CcSEcCtD
Eprosartan—Angina pectoris—Docetaxel—melanoma	0.00193	0.00318	CcSEcCtD
Eprosartan—Ill-defined disorder—Temozolomide—melanoma	0.00192	0.00317	CcSEcCtD
Eprosartan—Anorexia—Bleomycin—melanoma	0.00191	0.00315	CcSEcCtD
Eprosartan—Angioedema—Temozolomide—melanoma	0.00189	0.00312	CcSEcCtD
Eprosartan—Hypotension—Bleomycin—melanoma	0.00187	0.00309	CcSEcCtD
Eprosartan—Malaise—Temozolomide—melanoma	0.00187	0.00308	CcSEcCtD
Eprosartan—Vertigo—Temozolomide—melanoma	0.00186	0.00307	CcSEcCtD
Eprosartan—Palpitations—Temozolomide—melanoma	0.00183	0.00302	CcSEcCtD
Eprosartan—Thrombocytopenia—Dactinomycin—melanoma	0.00183	0.00302	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Bleomycin—melanoma	0.00183	0.00301	CcSEcCtD
Eprosartan—Chest pain—Carmustine—melanoma	0.00183	0.00301	CcSEcCtD
Eprosartan—Myalgia—Carmustine—melanoma	0.00183	0.00301	CcSEcCtD
Eprosartan—Anxiety—Carmustine—melanoma	0.00182	0.003	CcSEcCtD
Eprosartan—Cough—Temozolomide—melanoma	0.00181	0.00298	CcSEcCtD
Eprosartan—Paraesthesia—Bleomycin—melanoma	0.0018	0.00297	CcSEcCtD
Eprosartan—Dyspnoea—Bleomycin—melanoma	0.00179	0.00295	CcSEcCtD
Eprosartan—Anorexia—Dactinomycin—melanoma	0.00178	0.00294	CcSEcCtD
Eprosartan—Myalgia—Temozolomide—melanoma	0.00176	0.00291	CcSEcCtD
Eprosartan—Arthralgia—Temozolomide—melanoma	0.00176	0.00291	CcSEcCtD
Eprosartan—Anxiety—Temozolomide—melanoma	0.00176	0.0029	CcSEcCtD
Eprosartan—Discomfort—Temozolomide—melanoma	0.00174	0.00287	CcSEcCtD
Eprosartan—Decreased appetite—Bleomycin—melanoma	0.00174	0.00287	CcSEcCtD
Eprosartan—Renal failure—Docetaxel—melanoma	0.00173	0.00286	CcSEcCtD
Eprosartan—Neuropathy peripheral—Docetaxel—melanoma	0.00173	0.00285	CcSEcCtD
Eprosartan—Dry mouth—Temozolomide—melanoma	0.00173	0.00284	CcSEcCtD
Eprosartan—Pain—Bleomycin—melanoma	0.00171	0.00283	CcSEcCtD
Eprosartan—Conjunctivitis—Docetaxel—melanoma	0.00171	0.00283	CcSEcCtD
Eprosartan—Thrombocytopenia—Carmustine—melanoma	0.00171	0.00283	CcSEcCtD
Eprosartan—Tachycardia—Carmustine—melanoma	0.00171	0.00282	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0017	0.00281	CcSEcCtD
Eprosartan—Anorexia—Carmustine—melanoma	0.00167	0.00275	CcSEcCtD
Eprosartan—Epistaxis—Docetaxel—melanoma	0.00166	0.00274	CcSEcCtD
Eprosartan—Thrombocytopenia—Temozolomide—melanoma	0.00166	0.00273	CcSEcCtD
Eprosartan—Feeling abnormal—Bleomycin—melanoma	0.00165	0.00272	CcSEcCtD
Eprosartan—Hypotension—Carmustine—melanoma	0.00164	0.0027	CcSEcCtD
Eprosartan—Hyperhidrosis—Temozolomide—melanoma	0.00164	0.0027	CcSEcCtD
Eprosartan—Decreased appetite—Dactinomycin—melanoma	0.00163	0.00268	CcSEcCtD
Eprosartan—Fatigue—Dactinomycin—melanoma	0.00161	0.00266	CcSEcCtD
Eprosartan—Anorexia—Temozolomide—melanoma	0.00161	0.00266	CcSEcCtD
Eprosartan—Pain—Dactinomycin—melanoma	0.0016	0.00264	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Carmustine—melanoma	0.00159	0.00263	CcSEcCtD
Eprosartan—Urticaria—Bleomycin—melanoma	0.00159	0.00263	CcSEcCtD
Eprosartan—Rhinitis—Docetaxel—melanoma	0.00159	0.00262	CcSEcCtD
Eprosartan—Body temperature increased—Bleomycin—melanoma	0.00159	0.00261	CcSEcCtD
Eprosartan—Insomnia—Carmustine—melanoma	0.00158	0.00261	CcSEcCtD
Eprosartan—Paraesthesia—Carmustine—melanoma	0.00157	0.00259	CcSEcCtD
Eprosartan—Pharyngitis—Docetaxel—melanoma	0.00157	0.00259	CcSEcCtD
Eprosartan—Dyspnoea—Carmustine—melanoma	0.00156	0.00257	CcSEcCtD
Eprosartan—Oedema peripheral—Docetaxel—melanoma	0.00156	0.00257	CcSEcCtD
Eprosartan—Somnolence—Carmustine—melanoma	0.00156	0.00257	CcSEcCtD
Eprosartan—Feeling abnormal—Dactinomycin—melanoma	0.00154	0.00254	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Temozolomide—melanoma	0.00154	0.00254	CcSEcCtD
Eprosartan—Insomnia—Temozolomide—melanoma	0.00153	0.00252	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dactinomycin—melanoma	0.00153	0.00252	CcSEcCtD
Eprosartan—Visual impairment—Docetaxel—melanoma	0.00153	0.00252	CcSEcCtD
Eprosartan—Decreased appetite—Carmustine—melanoma	0.00152	0.00251	CcSEcCtD
Eprosartan—Paraesthesia—Temozolomide—melanoma	0.00152	0.0025	CcSEcCtD
Eprosartan—Dyspnoea—Temozolomide—melanoma	0.00151	0.00249	CcSEcCtD
Eprosartan—Somnolence—Temozolomide—melanoma	0.0015	0.00248	CcSEcCtD
Eprosartan—Constipation—Carmustine—melanoma	0.0015	0.00247	CcSEcCtD
Eprosartan—Pain—Carmustine—melanoma	0.0015	0.00247	CcSEcCtD
Eprosartan—Dyspepsia—Temozolomide—melanoma	0.00149	0.00245	CcSEcCtD
Eprosartan—Abdominal pain—Dactinomycin—melanoma	0.00148	0.00244	CcSEcCtD
Eprosartan—Body temperature increased—Dactinomycin—melanoma	0.00148	0.00244	CcSEcCtD
Eprosartan—Hypersensitivity—Bleomycin—melanoma	0.00148	0.00244	CcSEcCtD
Eprosartan—Decreased appetite—Temozolomide—melanoma	0.00147	0.00242	CcSEcCtD
Eprosartan—Fatigue—Temozolomide—melanoma	0.00146	0.0024	CcSEcCtD
Eprosartan—Constipation—Temozolomide—melanoma	0.00145	0.00238	CcSEcCtD
Eprosartan—Pain—Temozolomide—melanoma	0.00145	0.00238	CcSEcCtD
Eprosartan—Feeling abnormal—Carmustine—melanoma	0.00144	0.00238	CcSEcCtD
Eprosartan—Asthenia—Bleomycin—melanoma	0.00144	0.00237	CcSEcCtD
Eprosartan—Gastrointestinal pain—Carmustine—melanoma	0.00143	0.00236	CcSEcCtD
Eprosartan—Chills—Docetaxel—melanoma	0.00142	0.00234	CcSEcCtD
Eprosartan—Pruritus—Bleomycin—melanoma	0.00142	0.00234	CcSEcCtD
Eprosartan—Feeling abnormal—Temozolomide—melanoma	0.00139	0.0023	CcSEcCtD
Eprosartan—Body temperature increased—Carmustine—melanoma	0.00138	0.00228	CcSEcCtD
Eprosartan—Abdominal pain—Carmustine—melanoma	0.00138	0.00228	CcSEcCtD
Eprosartan—Gastrointestinal pain—Temozolomide—melanoma	0.00138	0.00228	CcSEcCtD
Eprosartan—Hypersensitivity—Dactinomycin—melanoma	0.00138	0.00227	CcSEcCtD
Eprosartan—Urticaria—Temozolomide—melanoma	0.00134	0.00222	CcSEcCtD
Eprosartan—Asthenia—Dactinomycin—melanoma	0.00134	0.00221	CcSEcCtD
Eprosartan—Abdominal pain—Temozolomide—melanoma	0.00134	0.0022	CcSEcCtD
Eprosartan—Body temperature increased—Temozolomide—melanoma	0.00134	0.0022	CcSEcCtD
Eprosartan—Back pain—Docetaxel—melanoma	0.00133	0.0022	CcSEcCtD
Eprosartan—Muscle spasms—Docetaxel—melanoma	0.00133	0.00218	CcSEcCtD
Eprosartan—Hypersensitivity—Carmustine—melanoma	0.00129	0.00213	CcSEcCtD
Eprosartan—Diarrhoea—Dactinomycin—melanoma	0.00128	0.00211	CcSEcCtD
Eprosartan—Vomiting—Bleomycin—melanoma	0.00127	0.0021	CcSEcCtD
Eprosartan—Rash—Bleomycin—melanoma	0.00126	0.00208	CcSEcCtD
Eprosartan—Dermatitis—Bleomycin—melanoma	0.00126	0.00208	CcSEcCtD
Eprosartan—Asthenia—Carmustine—melanoma	0.00126	0.00207	CcSEcCtD
Eprosartan—Hypersensitivity—Temozolomide—melanoma	0.00125	0.00205	CcSEcCtD
Eprosartan—Syncope—Docetaxel—melanoma	0.00124	0.00204	CcSEcCtD
Eprosartan—Palpitations—Docetaxel—melanoma	0.00122	0.00201	CcSEcCtD
Eprosartan—Asthenia—Temozolomide—melanoma	0.00121	0.002	CcSEcCtD
Eprosartan—Loss of consciousness—Docetaxel—melanoma	0.00121	0.002	CcSEcCtD
Eprosartan—Cough—Docetaxel—melanoma	0.0012	0.00198	CcSEcCtD
Eprosartan—Diarrhoea—Carmustine—melanoma	0.0012	0.00197	CcSEcCtD
Eprosartan—Pruritus—Temozolomide—melanoma	0.0012	0.00197	CcSEcCtD
Eprosartan—Nausea—Bleomycin—melanoma	0.00119	0.00196	CcSEcCtD
Eprosartan—Vomiting—Dactinomycin—melanoma	0.00119	0.00196	CcSEcCtD
Eprosartan—Rash—Dactinomycin—melanoma	0.00118	0.00194	CcSEcCtD
Eprosartan—Myalgia—Docetaxel—melanoma	0.00117	0.00193	CcSEcCtD
Eprosartan—Arthralgia—Docetaxel—melanoma	0.00117	0.00193	CcSEcCtD
Eprosartan—Chest pain—Docetaxel—melanoma	0.00117	0.00193	CcSEcCtD
Eprosartan—Dizziness—Carmustine—melanoma	0.00116	0.00191	CcSEcCtD
Eprosartan—Diarrhoea—Temozolomide—melanoma	0.00116	0.00191	CcSEcCtD
Eprosartan—Dry mouth—Docetaxel—melanoma	0.00115	0.00189	CcSEcCtD
Eprosartan—Dizziness—Temozolomide—melanoma	0.00112	0.00184	CcSEcCtD
Eprosartan—Vomiting—Carmustine—melanoma	0.00111	0.00183	CcSEcCtD
Eprosartan—Nausea—Dactinomycin—melanoma	0.00111	0.00183	CcSEcCtD
Eprosartan—Shock—Docetaxel—melanoma	0.00111	0.00182	CcSEcCtD
Eprosartan—Rash—Carmustine—melanoma	0.0011	0.00182	CcSEcCtD
Eprosartan—Dermatitis—Carmustine—melanoma	0.0011	0.00182	CcSEcCtD
Eprosartan—Thrombocytopenia—Docetaxel—melanoma	0.0011	0.00182	CcSEcCtD
Eprosartan—Tachycardia—Docetaxel—melanoma	0.0011	0.00181	CcSEcCtD
Eprosartan—Headache—Carmustine—melanoma	0.0011	0.00181	CcSEcCtD
Eprosartan—Vomiting—Temozolomide—melanoma	0.00108	0.00177	CcSEcCtD
Eprosartan—Anorexia—Docetaxel—melanoma	0.00107	0.00177	CcSEcCtD
Eprosartan—Rash—Temozolomide—melanoma	0.00107	0.00176	CcSEcCtD
Eprosartan—Dermatitis—Temozolomide—melanoma	0.00107	0.00176	CcSEcCtD
Eprosartan—Headache—Temozolomide—melanoma	0.00106	0.00175	CcSEcCtD
Eprosartan—Hypotension—Docetaxel—melanoma	0.00105	0.00173	CcSEcCtD
Eprosartan—Nausea—Carmustine—melanoma	0.00104	0.00171	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Docetaxel—melanoma	0.00102	0.00169	CcSEcCtD
Eprosartan—Insomnia—Docetaxel—melanoma	0.00102	0.00168	CcSEcCtD
Eprosartan—Paraesthesia—Docetaxel—melanoma	0.00101	0.00167	CcSEcCtD
Eprosartan—Nausea—Temozolomide—melanoma	0.001	0.00166	CcSEcCtD
Eprosartan—Dyspnoea—Docetaxel—melanoma	0.001	0.00165	CcSEcCtD
Eprosartan—Somnolence—Docetaxel—melanoma	0.001	0.00165	CcSEcCtD
Eprosartan—Dyspepsia—Docetaxel—melanoma	0.00099	0.00163	CcSEcCtD
Eprosartan—Decreased appetite—Docetaxel—melanoma	0.000978	0.00161	CcSEcCtD
Eprosartan—Fatigue—Docetaxel—melanoma	0.00097	0.0016	CcSEcCtD
Eprosartan—Constipation—Docetaxel—melanoma	0.000962	0.00159	CcSEcCtD
Eprosartan—Pain—Docetaxel—melanoma	0.000962	0.00159	CcSEcCtD
Eprosartan—Feeling abnormal—Docetaxel—melanoma	0.000927	0.00153	CcSEcCtD
Eprosartan—Gastrointestinal pain—Docetaxel—melanoma	0.00092	0.00152	CcSEcCtD
Eprosartan—Abdominal pain—Docetaxel—melanoma	0.000889	0.00147	CcSEcCtD
Eprosartan—Body temperature increased—Docetaxel—melanoma	0.000889	0.00147	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—melanoma	0.000857	0.00219	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000852	0.00217	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000848	0.00216	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—melanoma	0.000842	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL1—melanoma	0.000841	0.00214	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PLCB4—melanoma	0.000841	0.00214	CbGpPWpGaD
Eprosartan—Hypersensitivity—Docetaxel—melanoma	0.000829	0.00137	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00082	0.00209	CbGpPWpGaD
Eprosartan—Asthenia—Docetaxel—melanoma	0.000807	0.00133	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—F2R—melanoma	0.0008	0.00204	CbGpPWpGaD
Eprosartan—Pruritus—Docetaxel—melanoma	0.000796	0.00131	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000795	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2RL1—melanoma	0.000787	0.00201	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—HGF—melanoma	0.000787	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—melanoma	0.000784	0.002	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDNRB—melanoma	0.000775	0.00198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRAP1—melanoma	0.000771	0.00197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MYO7A—melanoma	0.000771	0.00197	CbGpPWpGaD
Eprosartan—Diarrhoea—Docetaxel—melanoma	0.00077	0.00127	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000745	0.0019	CbGpPWpGaD
Eprosartan—Dizziness—Docetaxel—melanoma	0.000744	0.00123	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—GRM3—melanoma	0.00074	0.00189	CbGpPWpGaD
Eprosartan—Vomiting—Docetaxel—melanoma	0.000715	0.00118	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—F2RL1—melanoma	0.000715	0.00182	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000714	0.00182	CbGpPWpGaD
Eprosartan—Rash—Docetaxel—melanoma	0.000709	0.00117	CcSEcCtD
Eprosartan—Dermatitis—Docetaxel—melanoma	0.000709	0.00117	CcSEcCtD
Eprosartan—Headache—Docetaxel—melanoma	0.000705	0.00116	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—KISS1—melanoma	0.000702	0.00179	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.000693	0.00177	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCR4—melanoma	0.000688	0.00175	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR1—melanoma	0.00068	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM3—melanoma	0.000672	0.00171	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—MC1R—melanoma	0.00067	0.00171	CbGpPWpGaD
Eprosartan—Nausea—Docetaxel—melanoma	0.000668	0.0011	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—TAS2R60—melanoma	0.000656	0.00167	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR7—melanoma	0.000642	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GRM1—melanoma	0.000642	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KISS1—melanoma	0.000637	0.00162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR1—melanoma	0.000617	0.00157	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MC1R—melanoma	0.000608	0.00155	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—melanoma	0.000608	0.00155	CbGpPWpGaD
Eprosartan—Losartan—ALB—melanoma	0.000594	0.512	CrCbGaD
Eprosartan—AGTR1—GPCR downstream signaling—RHOB—melanoma	0.000584	0.00149	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR7—melanoma	0.000583	0.00149	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GRM1—melanoma	0.000583	0.00149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000568	0.00145	CbGpPWpGaD
Eprosartan—Losartan—ABCB1—melanoma	0.000566	0.488	CrCbGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—melanoma	0.000558	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR2—melanoma	0.000532	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RHOB—melanoma	0.00053	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDN1—melanoma	0.000528	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RAC2—melanoma	0.000523	0.00133	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLCB4—melanoma	0.000497	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL1—melanoma	0.000497	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR2—melanoma	0.000483	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RAC2—melanoma	0.000475	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—WNT5A—melanoma	0.000468	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TRRAP—melanoma	0.000467	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CUL3—melanoma	0.000467	0.00119	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000459	0.00117	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKR1B10—melanoma	0.000454	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2R—melanoma	0.000452	0.00115	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.000451	0.00115	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000444	0.00113	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDNRB—melanoma	0.000438	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2RL1—melanoma	0.000422	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GAB2—melanoma	0.000414	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GNA11—melanoma	0.000414	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2R—melanoma	0.000411	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.000406	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDNRB—melanoma	0.000398	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM3—melanoma	0.000397	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR4—melanoma	0.000389	0.000992	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000389	0.000991	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GNAQ—melanoma	0.000385	0.00098	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000379	0.000967	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KISS1—melanoma	0.000377	0.00096	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GNA11—melanoma	0.000376	0.000958	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GAB2—melanoma	0.000376	0.000958	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000374	0.000955	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000374	0.000953	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.00037	0.000943	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.00037	0.000942	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SKI—melanoma	0.000365	0.00093	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR1—melanoma	0.000365	0.00093	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MC1R—melanoma	0.000359	0.000916	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—PIK3CA—melanoma	0.000359	0.000914	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT3—melanoma	0.000355	0.000905	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR4—melanoma	0.000353	0.0009	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GNAQ—melanoma	0.000349	0.00089	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000349	0.00089	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR7—melanoma	0.000344	0.000878	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GRM1—melanoma	0.000344	0.000878	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000344	0.000877	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.00034	0.000868	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SUFU—melanoma	0.000336	0.000856	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT3—melanoma	0.000322	0.000822	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000321	0.000818	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BCL2L11—melanoma	0.000313	0.000799	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RHOB—melanoma	0.000313	0.000799	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HDAC6—melanoma	0.000301	0.000767	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—melanoma	0.000298	0.00076	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000297	0.000757	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CSF2—melanoma	0.000291	0.000743	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000287	0.000732	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR2—melanoma	0.000285	0.000727	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—melanoma	0.000285	0.000727	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000284	0.000724	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RAC2—melanoma	0.000281	0.000716	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCA—melanoma	0.000279	0.000712	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFC—melanoma	0.000276	0.000705	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—WNT5A—melanoma	0.000276	0.000705	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—melanoma	0.000271	0.00069	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000268	0.000684	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CSF2—melanoma	0.000265	0.000675	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	0.00026	0.000662	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RAC1—melanoma	0.000259	0.00066	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCA—melanoma	0.000254	0.000647	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACER3—melanoma	0.000253	0.000644	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAP2K2—melanoma	0.000248	0.000632	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2R—melanoma	0.000243	0.000619	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RAC1—melanoma	0.000235	0.0006	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRB—melanoma	0.000235	0.000599	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UGT2B10—melanoma	0.000231	0.000589	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000228	0.000582	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTK2B—melanoma	0.000228	0.000582	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GAB2—melanoma	0.000222	0.000566	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNA11—melanoma	0.000222	0.000566	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FLT1—melanoma	0.000221	0.000563	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CG—melanoma	0.000219	0.000558	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HS3ST5—melanoma	0.000215	0.000548	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FOXO4—melanoma	0.000209	0.000532	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HDAC2—melanoma	0.000209	0.000532	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR4—melanoma	0.000209	0.000532	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNAQ—melanoma	0.000206	0.000526	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CG—melanoma	0.000199	0.000507	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SYK—melanoma	0.000194	0.000494	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CD—melanoma	0.000192	0.000491	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITGAV—melanoma	0.00019	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT3—melanoma	0.00019	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NGFR—melanoma	0.00019	0.000485	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS1—melanoma	0.000176	0.000449	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAP2K1—melanoma	0.000176	0.000448	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—melanoma	0.000176	0.000448	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CD—melanoma	0.000175	0.000445	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000173	0.000441	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ERBB4—melanoma	0.000168	0.000429	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CB—melanoma	0.000168	0.000428	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN2B—melanoma	0.000167	0.000425	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCB4—melanoma	0.000163	0.000415	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	0.000162	0.000414	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD86—melanoma	0.000161	0.000411	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—melanoma	0.000161	0.000411	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—melanoma	0.00016	0.000408	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00016	0.000408	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSF2—melanoma	0.000156	0.000399	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF1—melanoma	0.000156	0.000399	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—melanoma	0.000154	0.000393	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIP4K2A—melanoma	0.000153	0.00039	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC6A11—melanoma	0.000153	0.00039	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—E2F1—melanoma	0.000153	0.00039	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CB—melanoma	0.000152	0.000388	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDGFRA—melanoma	0.000151	0.000386	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITGB3—melanoma	0.00015	0.000382	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCA—melanoma	0.00015	0.000382	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTAP—melanoma	0.000149	0.00038	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPP1—melanoma	0.000147	0.000375	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAP2K2—melanoma	0.000147	0.000374	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—melanoma	0.000146	0.000373	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000146	0.000371	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—melanoma	0.00014	0.000357	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TERT—melanoma	0.000139	0.000355	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RAC1—melanoma	0.000139	0.000354	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HIF1A—melanoma	0.000133	0.00034	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PHGDH—melanoma	0.000133	0.000339	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LUM—melanoma	0.000133	0.000339	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HPSE—melanoma	0.00013	0.000332	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CUBN—melanoma	0.000128	0.000326	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KDR—melanoma	0.000127	0.000325	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SDHD—melanoma	0.000123	0.000315	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BSG—melanoma	0.000123	0.000315	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CSPG4—melanoma	0.000123	0.000315	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—melanoma	0.000123	0.000313	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH1—melanoma	0.00012	0.000306	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPAM—melanoma	0.00012	0.000305	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—melanoma	0.000118	0.0003	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KIT—melanoma	0.000117	0.000299	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CG—melanoma	0.000117	0.000299	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APC—melanoma	0.000117	0.000299	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NRAS—melanoma	0.000117	0.000299	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGF—melanoma	0.000116	0.000296	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK3—melanoma	0.000112	0.000287	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BRAF—melanoma	0.00011	0.000281	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—melanoma	0.000108	0.000274	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—melanoma	0.000107	0.000273	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EGFR—melanoma	0.000107	0.000273	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAP2K1—melanoma	0.000104	0.000265	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CD—melanoma	0.000103	0.000263	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CA—melanoma	0.000102	0.000261	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G6—melanoma	0.000102	0.000259	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KRAS—melanoma	0.000101	0.000258	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF2—melanoma	9.88e-05	0.000252	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CA—melanoma	9.28e-05	0.000237	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MDM2—melanoma	9.25e-05	0.000236	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—VCAN—melanoma	9.13e-05	0.000233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ERBB2—melanoma	9.12e-05	0.000232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CB—melanoma	9e-05	0.000229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—melanoma	8.65e-05	0.00022	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.64e-05	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HRAS—melanoma	8.59e-05	0.000219	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	8.44e-05	0.000215	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	8.35e-05	0.000213	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.34e-05	0.000213	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—melanoma	8.27e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—melanoma	8.26e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—melanoma	8.22e-05	0.00021	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCND1—melanoma	8.05e-05	0.000205	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	7.98e-05	0.000203	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—melanoma	7.82e-05	0.000199	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	7.79e-05	0.000199	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTEN—melanoma	7.77e-05	0.000198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—melanoma	7.74e-05	0.000197	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP17A1—melanoma	7.7e-05	0.000196	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.6e-05	0.000194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—melanoma	7.58e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.5e-05	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNA11—melanoma	7.28e-05	0.000185	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FASN—melanoma	7.12e-05	0.000182	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—melanoma	7.02e-05	0.000179	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC5A5—melanoma	7e-05	0.000179	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—melanoma	6.95e-05	0.000177	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRAS—melanoma	6.94e-05	0.000177	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNAQ—melanoma	6.76e-05	0.000172	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD44—melanoma	6.76e-05	0.000172	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK3—melanoma	6.64e-05	0.000169	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.62e-05	0.000169	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.56e-05	0.000167	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP1B1—melanoma	6.49e-05	0.000165	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MYC—melanoma	6.46e-05	0.000165	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—melanoma	6.32e-05	0.000161	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGFR—melanoma	6.32e-05	0.000161	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KRAS—melanoma	5.97e-05	0.000152	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.72e-05	0.000146	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	5.48e-05	0.00014	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCB1—melanoma	5.34e-05	0.000136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—melanoma	5.31e-05	0.000135	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRAS—melanoma	5.07e-05	0.000129	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRKCA—melanoma	4.92e-05	0.000125	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ERCC2—melanoma	4.87e-05	0.000124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—melanoma	4.86e-05	0.000124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—melanoma	4.48e-05	0.000114	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.04e-05	0.000103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CG—melanoma	3.85e-05	9.81e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—melanoma	3.72e-05	9.47e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CD—melanoma	3.38e-05	8.63e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—melanoma	3.34e-05	8.52e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CB—melanoma	2.95e-05	7.52e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—melanoma	2.92e-05	7.45e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTEN—melanoma	2.55e-05	6.5e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CA—melanoma	1.8e-05	4.58e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—melanoma	1.47e-05	3.75e-05	CbGpPWpGaD
